In this episode, Deciphex CEO Donal O’Shea featured on AI Ireland's podcast to share his journey from academia to entrepreneurship, and how he’s leading the charge in transforming global pathology services with AI. Donal discusses the growing demand for diagnostics, the importance of international collaboration, and how AI can support, not replace, pathologists in delivering faster, more accurate diagnoses around the world.
Published on
April 10, 2025
Category
AI
Discover more
Patholytix
Corporate
Global
AI
AI Improving Drug Safety, Reducing Burden Generating better results during preclinical research
AI improves drug safety assessments so unsafe drugs and compounds never make it to human clinical trials. Leveraging AI to reduce Animal Burden.
Cernostics and Deciphex Announce Strategic Collaboration to Develop AI-Based Histology Diagnostics and Prognostics for Barrett's Esophagus
By combining Deciphex’s unique digital pathology solutions with Cernostics tissue systems pathology approach, the partnership aims to generate novel predictive indicators using AI.
Diagnexia Analytix
Global
.png)
Deciphex Launches Diagnexia Analytix: AI-Driven Pathology Services for Translational Research and Development
Deciphex, the research pathology division of Deciphex, proudly announces the launch of Diagnexia Analytix, a comprehensive pathology service offering that integrates advanced analytics and AI-powered workflows with expert-led diagnostics to elevate study outcomes.
Deciphex launches CipherX: a step beyond foundation models, an AI engine for any pathology question
A complete pathology AI engine. Foundation models encode the structural elements of any tissue, an interpretative layer names and composes them into pathologist-validated signatures, and the surrounding tooling selects data, trains, optimises and validates. In production across Deciphex's clinical and research businesses.
Diagnexia Achieves Full UKAS Accreditation for Oxford Histopathology Laboratory and Digital Pathology Services
From Backlogs to Rapid Diagnosis: Diagnexia Secures Full UKAS Accreditation for End-to-End Histopathology Responding to increasing demand for reliable pathology reporting across the NHS, Diagnexia UK Limited has achieved UKAS accreditation* to ISO 15189:2022 for its Histology laboratory, Oxford, enabling trusts to access a fully accredited end-to-end histopathology service from specimen to digital report.
Deciphex Secures €15M Venture Debt Funding from Claret Capital Partners to Accelerate Growth
Strategic growth funding includes €10M immediate drawdown and restructuring of existing facilities to fuel US expansion and UK market leadership